PHILLIP HATLEY: Open Payments
NPI 1407448988 · ARDMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 28 payments from 16 companies in 2025. Trend: 2023 $128 · 2024 $16 · 2025 $863
Food & beverage: $522Travel & lodging: $341
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 1 | $341 |
| Neurocrine BioSciences, Inc. | 4 | $90 |
| UCB, Inc. | 4 | $71 |
| Merz Pharmaceuticals, LLC | 2 | $48 |
| GE HEALTHCARE | 2 | $38 |
| Lundbeck LLC | 2 | $36 |
| ABBVIE INC. | 2 | $35 |
| SK Life Science, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: VNS Therapy, INGREZZA, Nayzilam, Xeomin, VYEPTI, AUSTEDO XR, WAINUA, VYVGART.
Industry payments across OK — which companies pay providers there.
